WHAT'S NEW
- New: Doxycycline-PEP to Prevent Bacterial STIs (9/25/23)
- Updated: Substance Use Harm Reduction in Medical Care (9/25/23)
- Topics, Trends & Updates for September (9/14/23)
- Updated: Treatment of Opioid Use Disorder (9/12/23)
- New: Clinical Guidelines Program Approach to Shared Decision-Making (8/8/23)
- Topics, Trends & Updates for July (7/13/23)
- New Clinical Guidance: Stimulant Use (7/3/23)
- Updated: NYS Good Practices to Prevent Perinatal HIV Transmission (6/26/23)
- Updated: Diagnosis and Management of HIV-2 in Adults (6/20/23)
- Updated: HIV Resistance Assays (6/20/23)
- Updated: COVID-19 Immunization Recommendations (6/8/23)
- Updated: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (5/15/23)
- Topics, Trends & Updates for May (5/11/23)
- Updated: Second-Line ART After Treatment Failure or for Regimen Simplification (5/10/23)
- Updated: Immunizations recommendations -- MenB (5/9/23)
- Updated: Guidance: Addressing the Needs of Older Patients in HIV Care (5/5/23)
- Updated: ART Drug-Drug Interactions with lenacapavir (LEN) (4/26/23)
- Updated: Immunizations recommendations -- MenB, HBV, pneumococcal, and zoster (4/18/23)
- Topics, Trends & Updates for March (3/9/23)
- Updated: Substance Use Harm Reduction in Medical Care (2/28/23)
- Updated: Rapid ART Initiation (2/9/23)
- Updated: Second-Line ART After Treatment Failure or for Regimen Simplification (1/19/23)
- Topics, Trends & Updates for January (1/12/23)
- Updated: Immunizations for Adults With HIV (12/15/22)
- Topics, Trends & Updates for December (12/2/22)
MPOX & COVID-19 UPDATES
- CDC Update: Updated COVID-19 Vaccines are Recommended for Everyone Aged 6 Months and Older (9/13/23)
- FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants (9/11/23)
- NYCDOHMH: Providing COVID-19 Vaccines Following Commercialization (9/8/23)
- FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process (6/6/23)
- FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults (5/25/23)
- NYSDOH AI Dear Colleague Letter: New York State’s continued response to mpox (5/19/23)
- NYSDOH AI Health Advisory: Mpox Cases Associated with Person-to-Person Transmission (5/2/23)
- NYSDOH & NYCDOHMH Launch Mpox Vaccine Campaigns Urging Eligible New Yorkers to Prepare Now for a Healthy Summer (5/2/23)
- NYCDOHMH Dear Colleague: COVID-19 Vaccination Updates (4/21/23)
- FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines (4/18/23)
- NYSDOH AI & NYCDOHMH Mpox Dear Colleague Letter Announcing Spring and Summer Media Campaign (3/27/23)
- FDA Authorizes Bivalent Pfizer-BioNTech COVID-19 Vaccine as Booster Dose for Certain Children 6 Months through 4 Years of Age (3/14/23)
- FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses (2/27/23)
- NYCDOHMH: Bivalent COVID-19 Vaccines for Children Ages 6 Months Through 5 Years (12/14/22)
- FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age (12/8/22)
- NYSDOH Statement on Mpox Name Change (12/1/22)
- WHO Recommends New Name for Monkeypox Disease (11/30/22)
- NYCDOHMH: Novavax COVID-19 Boosters Allowed for People Ages 18 Years and Older (11/1/22)
- NYCDOHMH: Considerations for Monkeypox and Pregnant, Recently Pregnant, and Breastfeeding Patients (10/19/22)
- NYCDOHMH: Bivalent COVID-19 Booster Recommendation Expanded to Include Children Ages 5 to 11 Years (10/15/22)
- New NYS Regulation: Minor Consent Allowed for Monkeypox Services (10/14/22)
- FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups (10/12/2022)
- NYSDOH AI Dear Colleague Letter: COVID-19 Prevention & Treatment for Patients with HIV: Vaccines and Nirmatrelvir/Ritonavir (Paxlovid) (10/11/22)
- CDC: Severe Manifestations of Monkeypox among People who are Immunocompromised Due to HIV or Other Conditions (9/30/22)
- NYCDOHMH: Bivalent COVID-19 Boosters Recommended for Everyone Ages 12 Years and Older (9/17/22)
HOT TOPICS
- AETC NCRC: Quarterly Newsletter - Fall 2023 (9/26/23)
- CEI Newsletter (9/26/23)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (9/25/23)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Children with and Exposed to HIV (9/14/23)
- NYS Medicaid Update – August 2023 (9/11/23)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (9/7/23)
- USPSTF Final Recommendation Statement: PrEP for HIV Prevention (8/31/23)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Children with and Exposed to HIV (8/3/23)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (7/24/23)
- CEI's Courses Meet the DEA Education Requirement on Substance Use Disorders (7/18/23)
- NYSDOH AI: 2023 World AIDS Day Commissioner’s Special Recognition Awards Call for Nominations (7/10/23)
- NYSDOH AI: 2023 ETE Summit Call for Abstracts (7/10/23)
- NYSDOH AI: Interim Guidance for Public Health Law to require additional third trimester syphilis screening for pregnant persons (7/10/23)
- Complete CEI's HIV and Primary Care and Prevention Annual Survey by July 31, 2023 (7/5/23)
- NYCDOH&MH: Free CME on Providing Comprehensive Health Care for Men Who Have Sex With Men (6/30/23)
- NYS HIV Advisory Body (HAB) Recruitment Announcement (6/22/23)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (6/14/23)
- NYSDOH AI: Bicillin L-A Manufacturing and Supply Shortage Coinciding with Continued Syphilis Increases (6/6/23)
- NYSDOH AI: Call for Abstracts: 2023 Ending the Epidemic Summit & World AIDS Day Events (6/1/23)
- FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder (5/23/23)
- NYSDOH AI Dear Colleague Letter: Transition of pharmacy benefits in the New York State Medicaid program from Managed Care to the new NY Medicaid Pharmacy Program (NYRx) (4/20/23)
- FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use (4/13/23)
- HIVinfo: Updates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (4/11/23)
- CEI: NYS Medical Providers—2023 CEI Annual Survey (4/11/23)
- FDA Approves First Over-the-Counter Naloxone Nasal Spray (3/29/23)
CEI TRAINING & EVENTS
- 10/04/2023: HIV ECHO: Managing ART: 2023 Updates
- 10/11/2023: SH ECHO: Development of an Inclusive Peer-Led Sexual Health Education Program for Undergraduate Students: Experiences and Lessons Learned from SUNY Geneseo
- 10/23/2023: NYSDOH AI: PrEP Aware Week 2023
- 10/25/2023: DUH ECHO: Drug User Health ECHO
- 11/28/2023: NYSDOH AI: 2023 World AIDS Day and Ending the Epidemic Summit
GENERAL TRAINING & EVENTS
- 10/06/2023: NAHEWD: Bridging HIV & SUD: Xylazine and HIV in the Era of Synthetic Street Drugs
- 10/11/2023: IDWeek 2023
- 10/11/2023: MWAETC: 2023 HIV Continuum of Care Conference
- 10/17/2023: MWAETC: October 2023 AIDS Clinical Conference: Anal Cancer Prevention Update
- 10/18/2023: MA AETC: HIV & Depression: Screening, Interventions, and Impact on Care Continuum
- 10/23/2023: NYSDOH AI: PrEP Aware Week 2023
- 10/25/2023: ANAC2023
- 10/26/2023: International Workshop on HIV & Aging 2023
- 11/03/2023: NAHEWD: Bridging HIV & SUD: Law & Disorder: How the War on Drugs Impacts Drug User Health
- 11/08/2023: MA AETC: Trauma-Informed Care & HIV
- 11/28/2023: NYSDOH AI: 2023 World AIDS Day and Ending the Epidemic Summit
- 12/01/2023: NECA AETC: 26th Annual Controversies in the Management of the Patient with HIV
- 12/03/2023: IAS-USA: 2023 Ryan White HIV/AIDS Program (RWHAP) Clinical Conference
- 03/03/2024: CROI 2024